MultiPark: Multidisciplinary research focused on Parkinson´s disease

Organisational unit: Strategic research area

More filtering options
  1. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease.

    Carta, M., Carlsson, T., Munoz, A., Deniz Kirik & Anders Björklund, 2010, In : Movement Disorders. 25 Suppl 1, p. S174-S179

    Research output: Contribution to journalArticle

  2. The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective

    Carta, M. & Anders Björklund, 2018 Aug, In : Journal of Neural Transmission. 125, 8, p. 1195-1202

    Research output: Contribution to journalArticle

  3. α-Synuclein is a Novel Microtubule Dynamase

    Cartelli, D., Aliverti, A., Barbiroli, A., Santambrogio, C., Ragg, E. M., Casagrande, F. V. M., Cantele, F., Beltramone, S., Marangon, J., De Gregorio, C., Pandini, V., Emanuele, M., Chieregatti, E., Pieraccini, S., Holmqvist, S., Bubacco, L., Roybon, L., Pezzoli, G., Grandori, R., Arnal, I. & 1 others, Cappelletti, G., 2016 Sep 15, In : Scientific Reports. 6, 33289.

    Research output: Contribution to journalArticle

  4. Parkin absence accelerates microtubule aging in dopaminergic neurons

    Cartelli, D., Amadeo, A., Calogero, A. M., Casagrande, F. V. M., De Gregorio, C., Gioria, M., Kuzumaki, N., Costa, I., Sassone, J., Ciammola, A., Hattori, N., Okano, H., Goldwurm, S., Laurent Roybon, Pezzoli, G. & Cappelletti, G., 2018 Jan, In : Neurobiology of Aging. 61, p. 66-74

    Research output: Contribution to journalArticle

  5. Label-free concentration of viable neurons, hESCs and cancer cells by means of acoustophoresis.

    Castro Zalis, M., Reyes, J. F., Per Augustsson, Holmqvist, S., Laurent Roybon, Thomas Laurell & Tomas Deierborg, 2016, In : Integrative Biology. 8, 3, p. 332-340

    Research output: Contribution to journalArticle

  6. Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

    Catalán, M. J., Antonini, A., Calopa, M., Băjenaru, O., de Fábregues, O., Mínguez-Castellanos, A., Per Odin, García-Moreno, J. M., Pedersen, S. W., Pirtošek, Z. & Kulisevsky, J., 2017 Sep 1, In : eNeurologicalSci. 8, p. 44-53 10 p.

    Research output: Contribution to journalReview article

  7. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.

    Caudal, D., Alvarsson, A., Anders Björklund & Svenningsson, P., 2015, In : Experimental Neurology. 273, p. 243-252

    Research output: Contribution to journalArticle

  8. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

    Cederfjäll, E., Gurdal Sahin & Deniz Kirik, 2012, In : Neurobiology of Disease. 48, 2, p. 222-227

    Research output: Contribution to journalReview article

  9. Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson's disease.

    Cederfjäll, E., Broom, L. & Deniz Kirik, 2015, In : Molecular Therapy. 23, 5, p. 896-906

    Research output: Contribution to journalArticle

  10. Novel strategies for enzyme replacement with gene therapy in models of Parkinson’s disease

    Cederfjäll, E., 2014, Brain Repair and Imaging in Neural Systems (BRAINS). 140 p.

    Research output: ThesisDoctoral Thesis (compilation)

  11. Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.

    Cederfjäll, E., Nilsson, N., Gurdal Sahin, Chu, Y., Nikitidou, E., Tomas Björklund, Kordower, J. H. & Deniz Kirik, 2013, In : Scientific Reports. 3, 2157.

    Research output: Contribution to journalArticle

  12. Food chain transport of nanoparticles affects behaviour and fat metabolism in fish.

    Tommy Cedervall, Lars-Anders Hansson, Lard, M., Frohm, B. & Sara Linse, 2012, In : PLoS ONE. 7, 2, e32254.

    Research output: Contribution to journalArticle

  13. Translating scientific advances into disease-modifying therapies for Parkinson's Disease

    M. Angela Cenci & Olanow, C. W., 2017 Dec 1, In : Experimental Neurology. 298, p. 135-136 2 p.

    Research output: Contribution to journalArticle

  14. On the neuronal circuitry mediating l-DOPA-induced dyskinesia

    M. Angela Cenci, Henrik Jörntell & Per Petersson, 2018, In : Journal of Neural Transmission. 125, 8, p. 1157-1169

    Research output: Contribution to journalArticle

  15. Animal models of l-dopa-induced dyskinesia in Parkinson's disease

    M. Angela Cenci & Crossman, A. R., 2018 Jun 1, In : Movement Disorders. 33, 6, p. 889-899

    Research output: Contribution to journalReview article

  16. Dyskinesia matters

    M. Angela Cenci, Riggare, S., Pahwa, R., Eidelberg, D. & Hauser, R. A., 2019, In : Movement Disorders.

    Research output: Contribution to journalArticle

  17. Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?

    Angela Cenci Nilsson, Francardo, V., O'Sullivan, S. S. & Lindgren, H., 2015, In : Neurobiology of Disease. 82, aug 29, p. 561-573

    Research output: Contribution to journalReview article

  18. Post- Versus Pre-Synaptic Plasticity

    Angela Cenci Nilsson, 2010, In : Movement Disorders. 25, p. S582-S583

    Research output: Contribution to journalPublished meeting abstract

  19. Bad News for Neuroprotective Therapies in PD?

    Angela Cenci Nilsson & Brooks, D. J., 2013, In : Journal of Parkinson's Disease. 3, 3, p. 271-273

    Research output: Contribution to journalDebate/Note/Editorial

Previous 1...8 9 10 11 12 13 14 15 ...94 Next